Clinical Trial: MK0859 Dose-Ranging Study (0859-003)
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Efficacy, Safety, and Tolerability of MK-0859 in Patients With Primary Hypercholesterolemia or Mixed Hyper
Brief Summary: To assess the cholesterol changing effects of MK0859 in patients with primary hypercholesterolemia or mixed dyslipidemia.
Detailed Summary:
Sponsor: Merck Sharp & Dohme Corp.
Current Primary Outcome: To assess the cholesterol changing effects of MK0859
Original Primary Outcome:
Current Secondary Outcome: Acceptable safety profile
Original Secondary Outcome:
Information By: Merck Sharp & Dohme Corp.
Dates:
Date Received: May 11, 2006
Date Started: June 2006
Date Completion:
Last Updated: February 27, 2015
Last Verified: February 2015